LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "era novel" as a keyword



Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study

Sign Up to like & get
recommendations! Published in 2024 at "Cancer Medicine"

DOI: 10.1002/cam4.70270

Abstract: In the era of novel agents, the clinical outcomes of induction treatment and the impact of the number of high‐risk cytogenetic abnormalities (HRA) in newly diagnosed multiple myeloma (NDMM) need to be explored. read more here.

Keywords: induction treatment; novel agents; era novel; number high ... See more keywords

Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China

Sign Up to like & get
recommendations! Published in 2025 at "Cancer Medicine"

DOI: 10.1002/cam4.70573

Abstract: This study compares the efficacy and safety of single autologous stem cell transplantation (ASCT) versus tandem ASCT for multiple myeloma (MM) patients in the era of novel agents. read more here.

Keywords: multiple myeloma; cell transplantation; era novel; stem cell ... See more keywords

Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.

Sign Up to like & get
recommendations! Published in 2018 at "Leukemia research"

DOI: 10.1016/j.leukres.2018.02.010

Abstract: Primary plasma cell leukemia (PPCL) is a rare form of multiple myeloma with a dismal prognosis. This retrospective multi-center study examines the national experience of PPCL in the era of novel agents. During 2002-2016, thirty-nine… read more here.

Keywords: primary plasma; cell leukemia; novel agents; plasma cell ... See more keywords

Clinical and cytogenetic features of nonsecretory multiple myeloma (NSMM) in the era of novel agent induction therapy: The Mayo Clinic experience.

Sign Up to like & get
recommendations! Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.e19519

Abstract: e19519 Background: NSMM is a rare subtype of myeloma that has not been well characterized in the era of novel agent induction therapy. Thus, we evaluated the clinical and cytogenetic features of patients with newly… read more here.

Keywords: myeloma; era novel; novel agent; agent induction ... See more keywords